Regenxbio (RGNX) EBT Growth (3y) (2017 - 2025)
Regenxbio (RGNX) EBT Growth (3y) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
28.95% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-49.71% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
20.92% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
12.01% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Regenxbio |
315.11 Mn |
85.04 Mn |
- |
-32.09% |
| Date | Value |
|---|
| Dec 31, 2025 |
-32.09% |
| Sep 30, 2025 |
6.37% |
| Jun 30, 2025 |
-1.31% |
| Mar 31, 2025 |
27.63% |
| Dec 31, 2024 |
-29.40% |
| Sep 30, 2024 |
-0.69% |
| Jun 30, 2024 |
2.75% |
| Mar 31, 2024 |
-8.12% |
| Dec 31, 2023 |
-43.61% |
| Sep 30, 2023 |
-108.32% |
| Jun 30, 2023 |
-28.12% |
| Mar 31, 2023 |
-18.53% |
| Dec 31, 2022 |
47.56% |
| Sep 30, 2022 |
-29.51% |
| Jun 30, 2022 |
-250.31% |
| Mar 31, 2022 |
-33.45% |
| Dec 31, 2021 |
271.58% |
| Sep 30, 2021 |
-41.78% |
| Jun 30, 2021 |
-81.62% |
| Mar 31, 2021 |
-35.38% |
